| |
| |
|
| Insider
Information: |
Bhatt Padmanabh P. |
| Relationship: |
Sr. VP of IP, CSO |
| City: |
Rockville |
| State: |
MD |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
8,570 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$235,761 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
8,570 |
|
|
| Total
Value |
$235,761 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Supernus Pharmaceuticals Inc |
SUPN |
Sr. VP of IP, CSO |
2024-03-21 |
8,570 |
2012-06-18 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
65 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| SUPN |
Supernus Pharmaceuticals ... |
Sr. VP of IP, CSO |
• – – |
2024-03-12 |
4 |
OE |
$12.98 |
$50,414 |
D/D |
3,884 |
12,454 |
0 |
- |
|
| SUPN |
Supernus Pharmaceuticals ... |
Sr. VP of IP, CSO |
• – – |
2017-05-25 |
4 |
AS |
$34.90 |
$135,656 |
D/D |
(3,887) |
40,000 |
0 |
- |
|
| SUPN |
Supernus Pharmaceuticals ... |
Sr. VP of IP, CSO |
• – – |
2018-06-29 |
4 |
AS |
$59.90 |
$263,153 |
D/D |
(4,393) |
0 |
0 |
- |
|
| SUPN |
Supernus Pharmaceuticals ... |
Sr. VP of IP, CSO |
• – – |
2015-12-09 |
4 |
AS |
$14.90 |
$69,807 |
D/D |
(4,685) |
88,068 |
0 |
- |
|
| SUPN |
Supernus Pharmaceuticals ... |
Sr. VP of IP, CSO |
• – – |
2023-01-17 |
4 |
AS |
$39.92 |
$192,638 |
D/D |
(4,826) |
1,644 |
0 |
% |
|
| SUPN |
Supernus Pharmaceuticals ... |
Sr. VP of IP, CSO |
• – – |
2023-01-17 |
4 |
OE |
$9.13 |
$44,061 |
D/D |
4,826 |
6,470 |
0 |
- |
|
| SUPN |
Supernus Pharmaceuticals ... |
Sr. VP of IP, CSO |
• – – |
2015-11-04 |
4 |
AS |
$19.90 |
$99,500 |
D/D |
(5,000) |
102,306 |
0 |
- |
|
| SUPN |
Supernus Pharmaceuticals ... |
Sr VP of IP, CSO |
• – – |
2017-09-08 |
4 |
AS |
$49.86 |
$249,303 |
D/D |
(5,000) |
12,500 |
0 |
- |
|
| SUPN |
Supernus Pharmaceuticals ... |
Sr. VP of IP, CSO |
• – – |
2022-12-01 |
4 |
OE |
$9.13 |
$45,650 |
D/D |
5,000 |
6,644 |
0 |
- |
|
| SUPN |
Supernus Pharmaceuticals ... |
Sr. VP of IP, CSO |
• – – |
2022-12-01 |
4 |
AS |
$37.48 |
$187,416 |
D/D |
(5,000) |
1,644 |
0 |
% |
|
| SUPN |
Supernus Pharmaceuticals ... |
Sr. VP of IP, CSO |
• – – |
2024-02-26 |
4 |
OE |
$9.13 |
$45,650 |
D/D |
5,000 |
13,570 |
0 |
- |
|
| SUPN |
Supernus Pharmaceuticals ... |
Sr. VP of IP, CSO |
• – – |
2024-02-26 |
4 |
AS |
$30.21 |
$151,050 |
D/D |
(5,000) |
8,570 |
0 |
% |
|
| SUPN |
Supernus Pharmaceuticals ... |
Sr. VP of IP, CSO |
• – – |
2022-11-11 |
4 |
OE |
$9.24 |
$62,832 |
D/D |
6,800 |
8,444 |
0 |
- |
|
| SUPN |
Supernus Pharmaceuticals ... |
Sr. VP of IP, CSO |
• – – |
2022-11-11 |
4 |
AS |
$34.95 |
$237,655 |
D/D |
(6,800) |
1,644 |
0 |
% |
|
| SUPN |
Supernus Pharmaceuticals ... |
Sr. VP of IP, CSO |
• – – |
2018-06-21 |
4 |
OE |
$9.13 |
$65,782 |
D/D |
7,205 |
14,705 |
0 |
- |
|
| SUPN |
Supernus Pharmaceuticals ... |
Sr. VP of IP, CSO |
• – – |
2018-06-21 |
4 |
AS |
$60.00 |
$432,323 |
D/D |
(7,205) |
7,500 |
0 |
- |
|
| SUPN |
Supernus Pharmaceuticals ... |
Sr. VP of IP, CSO |
• – – |
2018-05-15 |
4 |
OE |
$9.13 |
$71,875 |
D/D |
7,868 |
15,000 |
0 |
- |
|
| SUPN |
Supernus Pharmaceuticals ... |
Sr. VP of IP, CSO |
• – – |
2018-05-15 |
4 |
AS |
$57.93 |
$455,759 |
D/D |
(7,868) |
7,500 |
0 |
- |
|
| SUPN |
Supernus Pharmaceuticals ... |
Sr. VP of IP, CSO |
• – – |
2015-12-08 |
4 |
AS |
$14.90 |
$142,341 |
D/D |
(9,553) |
92,753 |
0 |
- |
|
| SUPN |
Supernus Pharmaceuticals ... |
Sr. VP of IP, CSO |
• – – |
2017-06-02 |
4 |
AS |
$39.86 |
$398,558 |
D/D |
(10,000) |
27,500 |
0 |
- |
|
| SUPN |
Supernus Pharmaceuticals ... |
Sr. VP of IP, CSO |
• – – |
2017-04-24 |
4 |
AS |
$32.59 |
$384,762 |
D/D |
(11,806) |
45,500 |
0 |
- |
|
| SUPN |
Supernus Pharmaceuticals ... |
Sr. VP of IP, CSO |
• – – |
2024-03-19 |
4 |
OE |
$25.30 |
$312,809 |
D/D |
12,364 |
20,934 |
0 |
- |
|
| SUPN |
Supernus Pharmaceuticals ... |
Sr. VP of IP, CSO |
• – – |
2024-03-19 |
4 |
AS |
$35.31 |
$436,573 |
D/D |
(12,364) |
8,570 |
0 |
% |
|
| SUPN |
Supernus Pharmaceuticals ... |
Sr. VP of IP, CSO |
• – – |
2024-03-21 |
4 |
OE |
$25.30 |
$366,622 |
D/D |
14,491 |
23,061 |
0 |
- |
|
| SUPN |
Supernus Pharmaceuticals ... |
Sr. VP of IP, CSO |
• – – |
2024-03-21 |
4 |
AS |
$35.31 |
$511,677 |
D/D |
(14,491) |
8,570 |
0 |
% |
|
65 Records found
|
|
Page 2 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
